Blea, Baker Among California Veterinarians Hit With Accusations From Veterinary Medical Board

Three racetrack veterinarians in Southern California are the subjects of formal “accusation” documents from the state's veterinary medical board saying they violated a series of regulations governing their jobs. Dr. Jeff Blea, longtime racetrack practitioner and equine medical director for the California Horse Racing Board, is facing eight causes for discipline; Dr. Vince Baker, practitioner and managing licensee of Equine Medical Center in Cypress, Calif., faces 15 causes for discipline; Dr. Sarah Graybill Jones, a practitioner who works for Equine Medical Center, faces seven causes for discipline.

All three could see their veterinary licenses revoked or suspended, may be required to pay the Board back for reasonable costs of investigation, and/or be ordered to pay fines not exceeding $5,000.

The accusation documents represent the charges filed by the veterinary board. Hearings have yet to be held to determine whether and what disciplinary action may be taken.

The primary focus for much of the accusation documents involves record-keeping, both records of examination and diagnosis ahead of treatment and records of drugs dispensed, including controlled substances in some instances. In several cases, the veterinary medical board accuses the veterinarians of failing to establish a valid veterinary-client-patient relationship (VCPR) per state regulations because it's not clear from existing records that the veterinarians examined horses prior to dispensing medications.

The accusations outline the treatment of racehorses identified only by their initials and in large part, without trainer or owner names attached. The exception seems to be in the accusation document for Baker. As managing licensee of Equine Medical Center, he is considered to have some responsibility for the record-keeping of veterinarians working at the practice. A portion of the accusation document detailed records from other veterinarians at the clinic that seemed to similarly be missing identifying information, examination records, or treatment plans as required by law. In these cases, specific clients (trainers) were mentioned and included Carla Gaines, Doug O'Neill, and Bob Baffert. Baker has long been a key part of the veterinary team treating Baffert's horses, although in the accusation documents the medical board noted it was Jones who administered treatments to two unidentified Baffert horses and later billed the treatments under Baker's name.

The majority of substances listed in the documents are routine and legal therapeutic medications. By the veterinary medical board's legal definition, however, some were considered “dangerous” if they bore the phrase “RX only” on the label. Many, like Lasix, aren't considered by a layperson's definition to be inherently dangerous or exotic. Some of the drugs mentioned however, were also considered by the state to be misbranded because they were produced outside of federal oversight. Thyro-L, the trade name for levothyroxine powder, falls into this category as it is not FDA-approved and was allegedly dispensed by both Baker and Blea. Baker is also accused of using compounded substances from Buy Rite Drugs which were missing best usage dates, as well as Stop Two and EMP Drench, which the board also says fit the state's definition of misbranded drugs.

Some of the records the board considered to be inadequate from Baker's practice were for more tightly-regulated substances like Euthasol and ketamine.

An anonymous tip earlier this year prompted the investigation by the medical board into Blea in February. Blea took over his current role as CHRB equine medical director in June. In Baker's case, the medical board had performed a routine inspection of EMC's mobile unit in August 2019 and noted deficiencies in medical records and drug logs. The board visited the clinic's base in May 2020 and also received an anonymous complaint about Baker and others in February 2021.

Although identifying horse information was excluded in the documents, treatment dates were included. For Blea, they ranged from early 2020 to February 2021. For Baker, the dates ranged from January 2019 to August 2020. For Jones, the dates were concentrated in March 2020.

According to a report from the Los Angeles Times Dec. 23, an emergency hearing in Blea's case is scheduled for Dec. 24. The Times also notes that the position of equine medical director does not require an active veterinary license.

The post Blea, Baker Among California Veterinarians Hit With Accusations From Veterinary Medical Board appeared first on Horse Racing News | Paulick Report.

Source of original post

Judge Vacates Order To Sell Ramsey Horses At Keeneland; Owner Places Over $1 Million In Escrow For Ward Suit

A judge in Jessamine County Circuit Court has reversed his order to send 14 horses owned by Ken and Sarah Ramsey to the Keeneland January sale, reports bloodhorse.com, as part of an ongoing lawsuit by the couple's longtime trainer, Wesley Ward. Instead, the judge has allowed Ramsey to place $1,014,614.96 into escrow as security.

Ward brought suit against the Ramseys for unpaid bills in March of this year, claiming he was owed $974,790.40, which included training bills, purses, and interest. Around the same time, trainer Mike Maker also sued the couple for $905,357.29 in unpaid bills. Maker settled his case in September, with the terms of settlement undisclosed.

Ward had filed a motion in early December week seeking to be allowed to sell the horses, pointing out that he had filed agister's liens on them and obtained a warrant enforcing those liens. In March, Ward secured liens against a total of 44 Ramsey horses who contributed to the outstanding bills. According to court documents, Ward has sold a number of the horses who racked up the bills at public auction or via claiming and the 14 that remain are the only ones Ward still has in his barn.

Ramsey's attorney filed an emergency motion one day after the 14 were supplemented to the Keeneland January sale, requesting the judge vacate his order for sale, on the basis that the sale would cause “permanent and irreparable damage to Defendants that will not be made whole by mere money.”

“Following entry of the Court's order of sale, the supplement to the Keeneland January 2021 Horses of All Ages Sale has been released. It does not include the horses which are the subject of the Court's order of sale, which means the horses, their pedigrees, and past performances will not appear either in the catalog or the supplement for the sale,” the emergency order stated. “As a result, permitting the horses to be sold under such circumstances will cause substantial damages to Defendants.”

Ramsey's attorney Mike Meuser told bloodhorse.com that all 14 horses will be sent to another trainer in Florida.

Read more at bloodhorse.com.

The post Judge Vacates Order To Sell Ramsey Horses At Keeneland; Owner Places Over $1 Million In Escrow For Ward Suit appeared first on Horse Racing News | Paulick Report.

Source of original post

USADA Unable to Reach Deal With HISA Authority

The United States Anti-Doping Agency (USADA), for years a vocal proponent of federal legislation to bring the sport under a single governing entity, announced in a press release Thursday morning that it has been unable to reach an agreement to become the enforcement agency for the Horseracing Integrity and Safety Authority, the broad non-profit umbrella established by the Horseracing Integrity and Safety Act.

“After months of negotiations, we have been unable to enter an agreement in line with the requirements of the Act, and one which would have given us a reasonable chance to put in place a credible and effective program.  While we are obviously saddened by the outcome at this stage, we tried our absolute best to find a way forward but without success,” wrote Travis Tygart, USADA CEO, in a statement.

In a separate statement Thursday, the Authority confirmed the news. “As mandated by the Horseracing Integrity and Safety Act of 2020, USADA and HISA had been engaged in good faith negotiations but were unable to reach final terms,” the Authority wrote.

With the act scheduled to go into effect July 1 next year–provided it survives legal challenges in the interim–this announcement throws into disarray a crucial component of HISA.

That's because, with only six months left on the clock, the million-dollar question now is: What entity or entities will be responsible for overseeing HISA's laboratory accreditation, drug testing and enforcement program?

The law dictates that if USADA is not the contracted enforcement agency, the Authority must enter into an agreement “with an entity that is nationally recognized as being a medication regulation agency equal in qualification” to USADA.

In Thursday's statement, the Authority wrote that it is “evaluating options for engagement with other leading independent enforcement agencies.”

Furthermore, there will be a temporary delay in submission of the Anti-Doping and Medication Control draft rules to the FTC until a “new independent agency” can be identified and an agreement nailed down.

“This will allow HISA and another independent enforcement agency to reach an agreement and build on the progress that has been made to-date with USADA. HISA anticipates this process will permit the full implementation of the final ADMC rules in early 2023.”

According to the Authority, the draft Racetrack Safety regulations that were submitted to the FTC earlier this month will be implemented on July 1 next year, following the requisite review, public comment and education periods.

For many, this announcement will come as a bolt out of the blue.

Indeed, A little more than two weeks ago at the latest Race Track Industry Symposium at Tucson, Charles Scheeler, chairman of the Authority, unveiled a key development for what was to be the working mechanics of HISA's drug testing program.

According to Scheeler, individual states were going to continue conducting race-day testing and sample collection come July 1 next year. At the same time, USADA would manage the out-of-competition (OOC) testing program.

However, when the 2023 season rolls around, USADA was expected to assume responsibility for both race-day and OOC testing. That arrangement is now obviously defunct.

“While we desperately tried to reach an agreement to implement the program, without compromising our values, we have always said the passing of the legislation and the finalization of uniform, robust rules are huge victories for the horses and the equine industry,” Tygart wrote, in Thursday's statement.

“We are honored to have been involved with these efforts to restore the integrity of thoroughbred horse racing. Though we are unsure what the future holds for USADA–if any–in this effort, we have offered to assist the Authority and others in the industry to ensure that the sport gets the program it needs and that the horses deserve,” Tygart added.

In a statement Thursday, Scheeler said “We are deeply grateful for USADA's hard work, expertise and leadership in working with HISA's Anti-Doping and Medication Committee to develop comprehensive draft rules in a remarkably short period of time.”

NHBA President Eric Hamelback released the following statement, “The National HBPA continues to stand steadfast behind our belief that the HISA Act is an unconstitutional delegation of authority to a private organization. With that said, after the events announced today we hope members of the Authority take into strong consideration partnering with an enforcement agency that understands the nuances of the horse-racing industry and recognizes the significant positive strides this industry has made in both safety and integrity. Now would be a perfect opportunity for the Authority to mesh the safety regulations that have been put forth with the best of the model rules currently established throughout the United States.”

The TDN requested in-person interviews with both Tygart and someone from the Authority about the reasons underpinning Thursday's announcement, and where HISA stands now. These requests remain pending.

In the meantime, the news leaves dangling many key questions pertaining to the practical implementation of HISA. Among them are the following:

1 – Realistically, what entity or entities could step into the role of the enforcement agency?

Could a group like the United States Equestrian Federation pick up the reins? Or is there still a place for USADA to jump into the saddle?

2 – The issue of cost has been an albatross hanging around the neck of HISA from the start.

And so, when it comes to selecting any enforcement agency moving forward, is there a viable, affordable option for the industry that can still meet HISA's statutory needs?

3 – USADA has already put together and published several key materials outlining things like the prohibited substance list, the results management process, sanctions, and the equine sample collection procedure.

But how much of these materials is proprietary, meaning, the Authority would be forced back to the drawing board?

4 – Drugs are broken into two broad categories. Primary substances are those prohibited at all times. Secondary substances–like therapeutic medications–are prohibited just on race-day.

USADA's system was expected to do away with the current Association of Racing Commissioners International (ARCI)'s alphanumeric classification system for regulated drugs–class 1 through 5, and A through D.

Will the primary and secondary substances lists–the latter USADA hadn't publicly released–still be adopted as part of HISA's anti-doping and medication control rules program?

Or could we see a scenario where the ARCI's model rules remain in place? This last question leads onto the next.

5 – Could today's news facilitate a long-term expanded role for the Racing Medication and Testing Consortium (RMTC) under HISA, considering the agency already performs several key tasks under the Act's anti-doping and medication program?

For one, laboratories currently accredited by the RMTC were expected to be given interim accreditation for the last six months of 2022 as it was.

Furthermore, the ARCI's model rules are built upon the RMTC's scientific groundwork.

6 – As per USADA's results management program, a “National Steward Panel” would be responsible for hearing secondary substance violations, while “Impartial arbitrators” would hear those for primary substance violations.

This system was warmly received within the industry as an important break from the status quo.

But without USADA at the helm–and currently no firm idea as to who the enforcement agency will be–what is the likelihood these panels will be in place even by the start of 2023?

The post USADA Unable to Reach Deal With HISA Authority appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights